ACADIA HEALTHCARE COMPANY IN's ticker is ACHC and the CUSIP is 00404A109. A total of 255 filers reported holding ACADIA HEALTHCARE COMPANY IN in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,747,530 | -13.0% | 25,874 | +2.1% | 0.01% | -14.3% |
| Q1 2024 | $2,007,672 | +0.2% | 25,343 | -1.6% | 0.01% | -6.7% |
| Q4 2023 | $2,003,564 | +8.7% | 25,766 | -1.7% | 0.02% | -6.2% |
| Q3 2023 | $1,842,474 | -10.5% | 26,205 | +1.3% | 0.02% | -5.9% |
| Q2 2023 | $2,059,172 | +8.1% | 25,856 | -1.9% | 0.02% | 0.0% |
| Q1 2023 | $1,904,510 | -9.7% | 26,360 | +2.8% | 0.02% | -15.0% |
| Q4 2022 | $2,110,109 | +9.7% | 25,633 | +4.2% | 0.02% | 0.0% |
| Q3 2022 | $1,923,000 | +16.7% | 24,600 | +0.9% | 0.02% | +25.0% |
| Q2 2022 | $1,648,000 | +8.9% | 24,373 | +5.5% | 0.02% | +33.3% |
| Q1 2022 | $1,513,000 | +8.5% | 23,095 | +0.5% | 0.01% | +9.1% |
| Q4 2021 | $1,395,000 | -5.8% | 22,977 | -1.1% | 0.01% | -8.3% |
| Q3 2021 | $1,481,000 | +2.7% | 23,222 | +1.0% | 0.01% | 0.0% |
| Q2 2021 | $1,442,000 | +8.3% | 22,981 | -1.4% | 0.01% | 0.0% |
| Q1 2021 | $1,332,000 | +14.1% | 23,315 | +0.4% | 0.01% | +9.1% |
| Q4 2020 | $1,167,000 | +63.9% | 23,219 | -3.9% | 0.01% | +57.1% |
| Q3 2020 | $712,000 | +57.5% | 24,153 | +34.2% | 0.01% | +16.7% |
| Q2 2020 | $452,000 | +18.3% | 17,992 | -13.5% | 0.01% | -14.3% |
| Q1 2020 | $382,000 | -77.1% | 20,793 | -58.6% | 0.01% | -65.0% |
| Q4 2019 | $1,668,000 | -2.7% | 50,225 | -9.0% | 0.02% | -4.8% |
| Q3 2019 | $1,715,000 | -23.8% | 55,172 | -14.3% | 0.02% | -19.2% |
| Q2 2019 | $2,250,000 | +20.8% | 64,378 | +1.4% | 0.03% | +18.2% |
| Q1 2019 | $1,862,000 | +14.3% | 63,516 | +0.3% | 0.02% | +4.8% |
| Q4 2018 | $1,629,000 | -26.2% | 63,345 | +1.1% | 0.02% | 0.0% |
| Q3 2018 | $2,206,000 | -5.4% | 62,679 | +10.0% | 0.02% | -8.7% |
| Q2 2018 | $2,331,000 | +7.6% | 56,971 | +3.0% | 0.02% | +4.5% |
| Q1 2018 | $2,166,000 | +12.9% | 55,292 | -6.0% | 0.02% | +15.8% |
| Q4 2017 | $1,918,000 | -13.3% | 58,792 | +27.0% | 0.02% | -26.9% |
| Q3 2017 | $2,212,000 | +39.0% | 46,307 | +43.7% | 0.03% | +18.2% |
| Q2 2017 | $1,591,000 | – | 32,220 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P2 Capital Partners, LLC | 1,685,000 | $110,418,000 | 10.45% |
| Iron Triangle Partners LP | 502,640 | $32,938,000 | 3.92% |
| Integral Health Asset Management, LLC | 150,000 | $9,830,000 | 2.56% |
| SASCO CAPITAL INC / CT/ | 269,684 | $17,672,000 | 2.20% |
| Aristotle Capital Boston, LLC | 1,221,315 | $80,033,000 | 2.02% |
| Lisanti Capital Growth, LLC | 253,780 | $16,630,000 | 1.87% |
| Hawk Ridge Capital Management | 497,320 | $32,589,000 | 1.86% |
| Stephens Investment Management Group LLC | 1,599,971 | $104,846,000 | 1.54% |
| Sivik Global Healthcare LLC | 50,000 | $3,277,000 | 1.35% |
| Sapience Investments, LLC | 163,795 | $10,733,000 | 1.30% |